OBGYN & Reproduction Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of OBGYN & Reproduction Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Financing
Clinical testing laboratory enters equity distribution agreement
July 4th, 2005
NeoGenomics, Inc., (NGNM) announced that it has entered into a standby equity distribution agreement (SEDA) with Cornell Capital Partners, LP (Cornell). Pursuant to the SEDA, the company may, at its discretion, periodically sell to Cornell shares of common stock for a total purchase price of up to $5.0 million. For each share of common stock purchased under the SEDA, Cornell will pay the company 98% of the lowest volume weighted average price (VWAP) of the company's common stock as quoted by Bloomberg, LP on the Over-the-Counter Bulletin Board or other principal market on which the company's common stock is traded for the 5 days immediately following the notice...
Source: OBGYN & Reproduction Week (2005-07-04)
|
